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Abstract
Background: Proximal chromosome 15q is implicated in neurodevelopmental disorders including
Prader-Willi and Angelman syndromes, autistic disorder and developmental abnormalities resulting
from chromosomal deletions or duplications. A subset of genes in this region are subject to
genomic imprinting, the expression of the gene from only one parental allele.
Results: We have now identified the NDNL2 (also known as MAGE-G) gene within the 15q autistic
disorder susceptibility region and have mapped its murine homolog to the region of conserved
synteny near necdin (Ndn) on mouse Chr 7. NDNL2/MAGE-G is a member of a large gene family
that includes the X-linked MAGE cluster, MAGED1 (NRAGE), MAGEL2 and NDN, where the latter
two genes are implicated in Prader-Willi syndrome. We have now determined that NDNL2/Ndnl2
is widely expressed in mouse and human fetal and adult tissues, and that it is apparently not subject
to genomic imprinting by the PWS/AS Imprinting Center.
Conclusion: Although NDNL2/MAGE-G in the broadly defined chromosome 15 autistic disorder
susceptibility region, it is not likely to be pathogenic based on its wide expression pattern and lack
of imprinted expression.
Background
Human chromosome 15q is prone to cytogenetic rear-
rangements, in part due to repetitive elements located
therein [1,2]. Prader-Willi syndrome (PWS) and Angel-
man syndrome (AS) are two neurodevelopmental disor-
ders caused by deletions of 15q11-q13, and
neurodevelopmental abnormalities are associated with
supernumerary chromosomes derived from inverted du-
plications of 15q [3]. In addition, an autistic disorder sus-
ceptibility locus has been localized to proximal 15q by
linkage and association studies [4,5]. AS is associated
with UBE3A mutations [6,7]. Strong candidates for PWS
have recently emerged and are likely to have an additive
effect in causing this disorder [8–12]. In particular, two
members of the NDN/MAGE gene family, NDN and
MAGEL2, are located in the PWS deletion region and are
inactivated in individuals with PWS [8,11–14]. Respira-
tory and behavioral abnormalities in a mouse deleted for
Ndn, the murine orthologue of NDN, may suggest that
NDN is implicated in the PWS phenotype [15,16]. We
have therefore investigated the possibility that other
NDN/MAGE genes may also be present on proximal 15q
Published: 20 December 2001
BMC Genetics 2001, 2:22
Received: 1 October 2001
Accepted: 20 December 2001
This article is available from: http://www.biomedcentral.com/1471-2156/2/22
© 2001 Chibuk et al; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any non-com-
mercial purpose, provided this notice is preserved along with the article's original URL. For commercial use, contact info@biomedcentral.comBMC Genetics 2001, 2:22 http://www.biomedcentral.com/1471-2156/2/22
Page 2 of 7
(page number not for citation purposes)
and may be involved in neurodevelopmental disorders.
Indeed, we identified a novel necdin-related gene,
NDNL2, on proximal 15q within the critical region for
autistic disorder susceptibility. We have examined the
expression of NDNL2 and its murine orthologue, and
placed the murine gene on Chr. 7. The proximal region of
chromosome 15 is subject to genomic imprinting, the ex-
pression of a gene from only one allele depending on par-
ent-of-origin. Furthermore, the maternal derivation of
chromosome 15 abnormalities seen in individuals with
autistic disorder suggests a parent-of origin effect [4,5].
We have therefore analyzed the imprinting of human
and mouse NDNL2/Ndnl2.
Results and discussion
Using a BLAST search for genes with sequence similarity
to NDN, NDNL2 was identified as a MAGE-like protein
on the BAC clone RP11-18H24 (GenBank accession
AC016484). This clone also contains the APBA2 gene
which has been physically mapped to within the critical
region for a 15q autistic disorder susceptibility locus, and
outside the PWS/AS deletion region [4,5] (Fig. 1). An
open reading frame of 472 amino acids was predicted
from the genomic sequence of NDNL2 and is located
within a single exon of the predicted gene. A series of ex-
pressed sequence tags (ESTs) were identified through a
BLAST search of the EST database and were found to be
part of the Unigene cluster Hs.94011. Assembly of the
ESTs into a consensus sequence was performed and this
sequence was compared to our sequence of IMAGE
clones representing NDNL2 to arrive at a final sequence
for the predicted protein (Fig. 2) (also see partial se-
quence in GenBank AF320911, MAGE-G).
The sequence for murine Ndnl2 was identified using se-
quence data obtained from homology searches of mouse
ESTs (UniGene cluster Mm.19944). Comparison of the
sequence from multiple cDNAs revealed that the predict-
ed mouse protein has 279 amino acids and has 83% se-
quence identity with the human protein (Fig. 2). As with
other NDN/MAGE family members, the maximum se-
quence conservation is in the C-terminus of the protein,
suggesting a common function for this domain among
family members. The murine protein is truncated at the
N terminus compared to the human protein at the posi-
tion equivalent to the methionine at position 168 in the
human predicted protein, predicted based on the pres-
ence of a strong Kozak consensus surrounding the
murine AUG, including a G at the minus three position.
In at least two EST clones, including RIKEN clone
AK010294 from a library enriched for full-length cDNAs,
the predicted amino acids upstream of the putative
murine start methionine are not conserved with the hu-
man sequence, in sharp contrast with those C-terminal
to this methionine (Fig. 2). In addition, the lack of con-
servation does not appear to be due to the presence of an
intron or a sequencing error. Closer inspection of the se-
quence revealed that NDNL2 contains only partial simi-
larity to the antigenic nonapeptide characteristic of other
MAGE family proteins (Fig. 2). Ndnl2 is identical in se-
quence to a predicted protein named "mage-g1" (Gen-
Bank accession AF319979).
We identified a DNA polymorphism within Ndnl2 by di-
rect sequencing of a 469 bp PCR product amplified from
M. musculus strain C57BL/6JEi and M. spretus SPRET/
Ei DNA. The presence of a T to C transition at position 42
of AV005659 abolishes an Msp I site in C57BL/6JEi that
is present in SPRET/Ei. By genotyping the Jackson labo-
ratory BSS backcross derived from the cross (C57BL/
6JEi  ×  SPRET/Ei)F1 ×  SPRET/Ei), we demonstrated
linkage of Ndnl2 to chromosome 7, at a position geneti-
cally inseparable from that of Ndn (see Mouse Genome
Informatics,  [http://www.informatics.jax.org/]  for de-
tails). As predicted from the location of human APBA2
Figure 1
Map of the human 15q11-q14 region. Location of
NDNL2 was derived from the Ensembl Human Genome
server  [http://www.ensembl.org/]  and the physical location
of APBA2, which is located on the same genomic clone as
NDNL2. The large double-headed arrow indicates the com-
mon PWS/AS deletion, and BP2 and BP3 indicate the most
common proximal and distal breakpoint regions. The break-
point region for the largest inv dup (15) chromosome [27]
and the autistic disorder susceptibility region [5] are also
indicated. The physical distance between BP3 and APBA2/
NDNL2 is as yet unknown due to the presence of repetitive
elements in the intervening region.BMC Genetics 2001, 2:22 http://www.biomedcentral.com/1471-2156/2/22
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near NDNL2, the murine Apba2 gene is also located in
the central region of Chr 7, but the use of different map-
ping panels for the two genes does not permit their rela-
tive order to be established [17]. Based on the high
sequence similarity between human and mouse sequenc-
es and on the location in a region of conserved synteny
we conclude that the NDNL2 andNdnl2 genes are orthol-
ogous in these two species.
The expression of NDNL2 and Ndnl2 was analyzed by
northern blot studies (Fig. 3). The observed 1.9 kb RNA
transcript roughly corresponds in size to the 1.5 kb cDNA
present in IMAGE clone 1134795, which likely contains
most of the transcript. The transcript was observed in all
human tissues tested, and appeared to be most abundant
in testis after adjustments were made for RNA loading.
Expression in mouse is also widespread, with a moder-
ately abundant 1.7 kb transcript observed in all tissues
tested consistent with the 1.5 kb insert size for cDNA
clone RIKEN ID 1010001J10. The origin of the smaller
transcript in mouse testis is unknown but may represent
an alternative polyadenylation site or alternative tran-
scriptional start site. It is notable that expression of
NDNL2/Ndnl2 is widespread although for other family
members, including Ndn, Magel2 and Dlxin, the murine
homologue of MAGED1, expression is more spatially and
temporally limited [12,18,19].
Previous studies have suggested that the imprinted do-
main on chromosome 15q is limited to a region of about
1.5 Mb surrounding the imprinting center [20,21]. How-
ever, given the observed parent-of-origin effects in chro-
mosomal disorders of chromosome 15 [4], we performed
experiments to analyze the imprinting of NDNL2 and
Ndnl2. To test imprinting of Ndnl2, we examined new-
born brain, liver and lung, and embryonic day 12.5 whole
embryo RNA samples from the offspring of an interspe-
cific mouse cross for allelic expression using the same
murine MspI polymorphism as used for genetic map-
ping. Both parental alleles were detected equally, indi-
cating that expression of Ndnl2 is not imprinted (Fig.
4A). We were unable to identify an intragenic polymor-
phism in NDNL2 that would allow direct evaluation of
the levels of expression of each allele. Instead, we evalu-
ated the effect of deletion of the chromosome 15q11-q13
imprinting center (IC) on the expression of NDNL2. Spo-
radic PWS and AS patients with de novo deletions not
only have a loss of the genes located inside the deletion
interval, they also have a loss of the imprinting control
element located therein. In a previous study, a somatic,
de novo deletion of the IC impaired imprinting of target
genes [22]. These target genes are not necessarily limited
to the region typically deleted in PWS and AS, which is
defined by unstable genomic elements located at the de-
letion boundaries [1], but could include other genes with-
in the range of the imprinting center. However, our
previous study had predicted that it is unlikely that the
range of the IC extended beyond the deletion itself [20].
To test this hypothesis and to examine the possibility
that NDNL2 is acted on by the IC, we tested the effect of
the loss of the IC in sporadic PWS and AS patients on the
expression of NDNL2. Using a previously defined assay
[20], RNA from lymphoblast and fibroblast cell lines that
carry either a paternal 15q11-q13 deletion (PWS) or the
Figure 2
Sequence comparison of human NDNL2 and mouse Ndnl2 sequence. The human and mouse predicted amino acid
sequences are aligned with conserved amino acids shaded. Partial sequence of two cDNA clones has been included for com-
parison of the predicted translation with the longer human open reading frame. The predicted position of a MAGE-like non-
apeptide present in other MAGE proteins is underlined.BMC Genetics 2001, 2:22 http://www.biomedcentral.com/1471-2156/2/22
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equivalent maternal deletion (AS) were tested by RT-
PCR for expression of NDNL2. On repeated trials, both
cell lines expressed NDNL2, indicating that NDNL2 is
not imprinted by the imprinting center located in the de-
letion region (Fig. 4B).
The names NDNL2/Ndnl2 have been approved by the
human and mouse nomenclature committees, based on
sequence similarity to NDN and chromosomal localiza-
tion. In a recent review of the NDN/MAGE gene family,
a multiple sequence alignment clustered the chromo-
some 15 family members (NDN, MAGEL2/NDNL1, and
NDNL2/MAGE-G) together with the X-linked MAGE-D,
MAGE-E and chromosome 3-linked MAGE-F genes
[23]. MAGE-D, known more commonly as NRAGE (hu-
man) or dlxin (mouse) may be ancestral to other mem-
bers of the NDN/MAGE gene family. We recommend
that the human and mouse nomenclature committees
evaluate the arguments for the names of genes in this
gene family to establish a unified nomenclature that clar-
ifies the relationships among the family members.
Necdin was originally identified as a gene induced on
neuronal differentiation of embryonic carcinoma cells,
but has more recently been implicated in PWS. Members
of the MAGE gene family are recognized for their expres-
sion in tumor cells, and a new family member MAGED1
(NRAGE/dlxin) is postulated to have roles in chondro-
genesis, neurotrophin signaling and apoptosis
[19,24,25]. Although the widespread expression of
NDNL2 does not immediately suggest a role in the neu-
rodevelopmental disorders associated with abnormali-
ties of chromosome 15, NDNL2 is located within the
broad region associated with developmental disorders.
Figure 3
Expression analysis necdin-like 2 in embryonic and adult human and mouse tissues. (A) Northern blots of adult
(left and center) and fetal (right) human tissues. The 1.9 kb NDNL2 transcript is indicated by the arrow. Size markers are as
indicated. (B) Northern blot of adult (left) and embryonic (right) mouse tissues shows expression of a 1.7 kb transcript
(arrow).BMC Genetics 2001, 2:22 http://www.biomedcentral.com/1471-2156/2/22
Page 5 of 7
(page number not for citation purposes)
In particular, the location of NDNL2 near D15S1019,
proximal to D15S165 implies that copies of NDNL2 are
present on most phenotypically relevant inv dup(15)
chromosomes [26,27] and may contribute to the findings
in patients carrying these supernumerary chromosomes
through a doubling of NDNL2 expression levels. Howev-
er, NDNL2 is outside the more narrowed interstitial du-
plication interval associated with some autistic
phenotypes [28], although long range effects on NDNL2
expression may still occur.
Conclusions
Given the wide range of processes that members of this
intriguing gene family participate in and the possibility
of redundant function within the gene family, we suggest
that the 15q NDN/MAGE family members be considered
as candidates for involvement in the neurodevelopmen-
tal disorders associated with chromosome 15q.
Materials and methods
cDNA clones
Human and mouse cDNAs were obtained from Research
Genetics or the MRC Genome Resource Facility and were
sequenced using the Thermo Sequenase fluorescent la-
beled primer cycle sequencing kit with 7-deaza dGTP
(Amersham-Phamacia Biotech, Buckinghamshire, Eng-
land) and LiCor technology (LiCor 4200 Automatic Se-
quencer, Lincoln, Nebraska). The human cDNA was
represented by IMAGE clone 1147395; mouse cDNAs
were IMAGE clones 483464, 2101532 and RIKEN
#1010001J10.
Northern blot expression studies
A PCR product derived from the 3' end of human NDNL2
was generated with oligonucleotide primers NDNL2-3F
(5'-GTCTACCCCACCAAGAAGCA) and NDNL2-4R (5'-
CCTTCCCCCAATCCTCTAAA), in a 20 µl PCR reaction
containing 20 pmol of each oligonucleotide. The PCR
was performed as follows: 94°C for 5 min. followed by 30
cycles of 94°C for 30 s, 52°C for 30 s, 72°C for 30 s, and
final extension at 72°C for 10 min., The PCR product was
random prime 32P-dCTP labeled with the Random Prim-
ers DNA Labeling System (Life Technologies, Rockville,
MD). The labeled probe was hybridized to human adult
and fetal Multiple Tissue Northern (MTN) Blots (Clon-
tech Laboratories, Palo Alto, CA., Cat. #7760–1, 7759–1
and 7756–1) in ExpressHyb solution according to manu-
facturer's directions. The final wash was at 50°C in
0.1XSSC, 0.1%SDS twice for 20 min each time. Exposure
to Hyperfilm (Amersham-Pharmacia Biotech) was for
Figure 4
Imprinting analysis of NDNL2/Ndnl2. (A) Restriction digestion of PCR of genomic DNA from C57BL/6, SPRET and an F1
offspring demonstrating the interspecific polymorphism, RT-PCR of tissues (nb = newborn) from the F1 offspring. Note that
both alleles are active. (B) RT-PCR of fibroblast (FB) and lymphoblast (LCL) RNA from PWS, AS and control samples. NDNL2
is expressed in all cell lines whereas SNRPN is not expressed in PWS cell lines (i.e. is imprinted).BMC Genetics 2001, 2:22 http://www.biomedcentral.com/1471-2156/2/22
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four days at -80°C. Oligonucleotide primers Ndnl2-1F
(5'-CTTGGAGTACCGGAGGATACC) and Ndnl2-2R (5'-
CAACACATCCTAACGCTCCA) were used for mouse
northern blots. These primers amplified a 343 bp DNA
fragment corresponding to the 3' end of the Ndnl2 gene.
The PCR was performed as above but with an annealing
temperature of 58°C. Mouse adult and embryo MTN
blots (Cat. #7762–1 and 7763–1, Clontech Laboratories)
were similarly hybridized with the radioactively labeled
Ndnl21F/2R PCR product. To control for the amount of
loaded RNA the same blot was subsequently hybridized
with a β -actin or ubiquitin probe demonstrating approx-
imately equal loading in all lanes.
Genetic mapping and imprinting studies
A 469 bp product corresponding to the 3' end of Ndnl2
was generated from mouse genomic DNA (C57BL/J or
SPRET/Ei) using oligonucleotide primers Ndnl2-7F (5'-
TGGAAACCAGCAAGATGAAA) and Ndnl2-8R (5'-
AGCTACCCTGTTTCTTTATCGTC). DNA samples were
sequenced on both strands using the LiCor automated
sequencer. DNA amplification products were digested
with MspI to produce a 469 bp undigested product in
C57BL/6J and 180 bp and 289 bp digested products in
DNA from M. spretus. Genetic mapping was performed
on the Jackson Laboratories BSS backcross. Cell lines
used for human imprinting analysis were PWS lymphob-
last GM09024B and AS lymphoblast GM11515 (both
from the NIGMS Human Genetic Mutant Cell Reposi-
tory), PWS fibroblast 1889 from the University of Miami
Brain and Tissue Bank for Developmental Disorders and
AS fibroblast KAT graciously provided by Dr. A. Beaudet
(Baylor College of Medicine).
List of abbreviations
AS (Angelman syndrome), ESTs, (expressed sequence
tags), IC (imprinting center), PWS (Prader-Willi syn-
drome).
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